1
|
Visentin A, Mauro FR, Cibien F, Vitale C, Reda G, Fresa A, Ciolli S, Pietrasanta D, Marchetti M, Murru R, Gentile M, Rigolin GM, Quaglia FM, Scarfò L, Sportoletti P, Pravato S, Romano Gargarella L, Facco M, Piazza F, Marchetti M, Coscia M, Laurenti L, Molica S, Pizzolo G, Foà R, Cuneo A, Trentim L. EFFICACY AND DISCONTINUATION RATE OF IBRUTINIB IN TREATMENT NAIVE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH TP53 ABNORMALITIES. A REAL‐LIFE CAMPUS CLL STUDY. Hematol Oncol 2021. [DOI: 10.1002/hon.46_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- A. Visentin
- Hematology and Clinical Immunology Unit, Department of Medicine University of Padova Padova Italy
| | - F. R. Mauro
- Hematology Unit, Department of Translational and Precision Medicine Sapienza" University Rome Italy
| | - F. Cibien
- Hematology Unit Ca’ Foncello Hospital Treviso Italy
| | - C. Vitale
- Department of Molecular Biotechnology and Health Sciences University of Torino and Division of Hematology A.O.U. Città della Salute e della Scienza di Torino Torino Italy
| | - G. Reda
- Hematology Unit Fondazione IRCCS Ca' Granda Ospedale Maggiore Milan Italy
| | - A. Fresa
- Hematology Institute Fondazione Policlinico Universitario Agostino Gemelli IRCSS Roma Italy
| | - S. Ciolli
- Hematology Unit, Careggi Hospital University of Florence Florence Italy
| | - D. Pietrasanta
- Division of Hematology A.O. SS Antonio e Biagio and Cesare Arrigo Alessandria Italy
| | - M. Marchetti
- Division of Hematology A.O. SS Antonio e Biagio and Cesare Arrigo Alessandria Italy
| | - R. Murru
- Hematology and Stem Cell Transplantation Unit Ospedale A. Businco, ARNAS “G. Brotzu Cagliari Italy
| | - M. Gentile
- Hematology unit, Department of Hemato‐Oncology Annunziata Hospital Cosenza Italy
| | - G. M. Rigolin
- Hematology section, Department of Medical Sciences Azienda Ospedaliera‐Universitaria, Arcispedale S. Anna, University of Ferrara Ferrara Italy
| | - F. M. Quaglia
- Department of Medicine, Section of Hematology University of Verona & Azienda Ospedaliera Universitaria Integrata Verona Italy
| | - L. Scarfò
- Strategic program on CLL University health and Science “San Raffaele Milan Italy
| | - P. Sportoletti
- Hematology and Clinical Immunology unit University of Perugia Perugia Italy
| | - S. Pravato
- Hematology and Clinical Immunology Unit, Department of Medicine University of Padova Padova Italy
| | - L. Romano Gargarella
- Hematology and Clinical Immunology Unit, Department of Medicine University of Padova Padova Italy
| | - M. Facco
- Hematology and Clinical Immunology Unit, Department of Medicine University of Padova Padova Italy
| | - F. Piazza
- Hematology and Clinical Immunology Unit, Department of Medicine University of Padova Padova Italy
| | - M. Marchetti
- Division of Hematology A.O. SS Antonio e Biagio and Cesare Arrigo Alessandria Italy
| | - M. Coscia
- Department of Molecular Biotechnology and Health Sciences University of Torino and Division of Hematology A.O.U. Città della Salute e della Scienza di Torino Torino Italy
| | - L. Laurenti
- Hematology Institute Fondazione Policlinico Universitario Agostino Gemelli IRCSS Roma Italy
| | - S. Molica
- Department Hematology‐Oncology Azienda Ospedaliera Pugliese‐Ciaccio Catanzaro Italy
| | - G. Pizzolo
- Department of Medicine, Section of Hematology University of Verona & Azienda Ospedaliera Universitaria Integrata Verona Italy
| | - R. Foà
- Hematology Unit, Department of Translational and Precision Medicine Sapienza" University Rome Italy
| | - A. Cuneo
- Hematology section, Department of Medical Sciences Azienda Ospedaliera‐Universitaria, Arcispedale S. Anna, University of Ferrara Ferrara Italy
| | - L. Trentim
- Hematology and Clinical Immunology Unit, Department of Medicine University of Padova Padova Italy
| |
Collapse
|